Partial sale
Index et al. partially exit Funxional Therapeutics
Index Ventures, Novo A/S and Ventech have partially exited their investment in Funxional Therapeutics, following the companyтs sale of its rights to lead anti-inflammatory drug FX 125L to German pharmaceuticals company Boehringer Ingelheim.
3i sells LNI stake for €36m
3i Group has sold its 5.7% stake in Lakeside Network Investments (LNI) to Teachers Insurance and Annuity Association of America for тЌ36m.
Hellman & Friedman buys Wood Mackenzie in £1.1bn SBO
Hellman & Friedman has acquired a majority stake in UK-based consultancy Wood Mackenzie from Charterhouse in a deal that values the business at ТЃ1.1bn.
De Persgroep Netherlands acquires 80% of PE-backed VNU Media
The Dutch arm of Belgian media company De Persgroep has acquired an 80% stake in Netherlands-based VNU Media, which is jointly held by 3i and HIG Capital.
Terra Firma in partial exit from Phoenix Group
Phoenix Group, a portfolio company of Terra Firma, has agreed to sell subsidiary Phoenix Supply to Northern Irish gas supplier Airtricity.
PE-backed Gala Coral to sell casinos for £205m
PE-backed Gala Coral has agreed to sell its UK casinos business to bingo and casino operator Rank for ТЃ205m.
Advent International's GFKL sells GENEVA-ID
Advent International’s portfolio company GFKL Financial Services AG has sold its subsidiary GENEVA-ID GmbH to SUBITO AG.
RJD reaps 1.5x on partial exit from Raphael Healthcare
RJD Partners has partially exited Raphael Healthcare in a refinancing, which has returned 1.5x of the original investment.
AXA PE buys Ouvêo group
AXA Private Equity has acquired French window manufacturer Ouvêo from Alliance Entreprendre and FSI Régions (formerly Avenir Entreprises), in a transaction valued at less than €50m.
NiXEN buys Babeau Seguin from Siparex et al.
NiXEN has acquired a majority stake of slightly more than 50% in French home construction group Babeau Seguin from a consortium of private equity shareholders.
Gimv sells part of Tinubu Square stake
Gimv has sold the largest part of its minority stake in French credit risk solutions provider Tinubu Square to sovereign wealth fund FSI.
Astorg buys Microconnections from Bain's FCI
Astorg Partners has acquired Microconnections from French connectors manufacturer FCI, a portfolio company of Bain Capital.
Bridgepoint exits Protocol Education
Bridgepoint has sold Protocol Education, part of its portfolio company Protocol Associates, to Graphite Capital.
Paine & Partners buys Scanbio from Verdane
Paine & Partners has acquired fish oil and protein concentrate producer Scanbio Marine Group from Scanbio AS, part-owned by Verdane Capital IV.
Ventizz sells stake in vitronet
Ventizz Capital Partners has together with the company’s management sold a 15% stake in broadband network specialist vitronet to RWE Deutschland.
Incitia partially exits Algeta – reaps 8x
Incitia Ventures has sold 50% of its shareholding in Oslo-based biotech company Algeta ASA, generating an 8x return on investment.
FSN Capital's Baggium sells C&T division
FSN Capitalтs portfolio company Baggium AB has sold its Care & Treatment division to Humana AB.
BC Partners further exits Médica
TBU-3 International, a holding owned by BC Partners, has sold a 28.1% stake in listed French homecare company Médica.
Bridgepoint secures loans to extend debt of Dorna Sports
Bridgepoint has secured €420m of loans to extend the debt of Spanish Dorna Sports SL, a motorcycle sports business that promotes and manages MotoGP (the Motorcycle Road Racing World Championship), say media reports.
DBAG sells Preh
Private equity firm Deutsche Beteiligungs AG (DBAG) has sold automotive supplier Preh to US supplier Joyson Automotive Electronic Holding.
CNPEF and Fondamenta sell 50% of Ares Line
Cape Natixis Private Equity Fund (CNPEF) and Fondamenta SGR have sold a 50% stake in Ares Line S.r.l. for approximately €5m equity.
CapMan's Cardinal Foods sells Norsk Kylling
CapManтs portfolio company Cardinal Foods has sold its subsidiary Norsk Kylling to REMA Industrier.
EQT-owned Gambro sells CaridianBCT
EQT and Investor-backed Gambro AB has sold CaridianBCT to Terumo Corporation for an enterprise value of $2.625bn.
Altor sells Ferrosan to Pfizer
Altor has sold Danish consumer health company Ferrosan Consumer Health (FCH) to Pfizer Inc.